Clinical Trial Update: First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating first-line temozolomide alone for non-enhancing adult brainstem gliomas with diffuse infiltrative progression pattern.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brainstem Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Adult Brainstem Glioma | Phase 2 | Status: UNKNOWN